Home » EC Wants Pediatric Trial Plans to Reflect Drug Delivery Options
EC Wants Pediatric Trial Plans to Reflect Drug Delivery Options
November 11, 2013
When adding a pediatric indication to a drug product, drugmakers are advised to consider a range of different pharmaceutical forms and formulations that might be more suitable for children, a draft revision to European Commission guidelines on pediatric investigation plans says.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor